# Final Remediation Report

## Executive summary

This remediation run consumed audit set `20260306T151338Z`, implemented all Batch A and Batch B approved fixes, strengthened related contract and negative-path tests, and reran full regression validation.

## Audit set consumed

- `docs/audit/production-readiness-expanded-capabilities/20260306T151338Z--*.md` (complete set)

## Findings remediated

- `RB-001` / `SH-CRIT-001`: fixed active orchestration write-intent propagation.
- `SH-HIGH-002`: fixed direct originate destination validation hardening.
- `SH-HIGH-003`: fixed self-healing write-governance ticket strictness.

## Findings deferred

- `SH-MED-004`
- `SH-MED-005`
- `OP-MED-001`

## Tests and validations added

- Added/updated tests for Batch A/B positive + negative paths.
- Full suite rerun: `221 passed, 2 skipped in 1.01s`.

## Readiness score impact

- Baseline score at audit time: `72/100`.
- Post-remediation qualitative impact: improved safety/gating correctness and governance traceability in active/remediation paths.
- Numeric score recomputation deferred to fresh production-readiness audit rerun.

## Remaining blockers

- No unresolved Batch A/B blockers from the selected audit set.
- Deferred Batch C/D items remain non-blocking for this remediation scope but still required for stronger pilot/production confidence.

## Recommended rollout class

- `Internal Pilot Ready with Conditions`

## What is safe now

- Read-only observability, auditing, scorecards, and evidence export paths.
- Lab-safe active smoke/probe orchestration with explicit write intent.
- Write-capable self-healing only with explicit ticketing and existing gating.

## What remains lab-only

- Class C active probes and active smoke.
- Lab-mode chaos scenarios.
- Risk-class B/C self-healing policy execution.

## What still must not ship

- Any production rollout that treats deferred `SH-MED-004`/`SH-MED-005`/`OP-MED-001` as completed.
- Any configuration that weakens existing mode, target-eligibility, and write-intent gate boundaries.
